Neurometabolic disorder due to serine deficiency

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

10 events
Feb 2026GLYCOPYRROLATE: New indication approved
FDAcompleted
Sep 2025GLYCOPYRROLATE: New indication approved
FDAcompleted
Jul 2025GLYCOPYRROLATE: New indication approved
FDAcompleted
Jul 2024GLYCOPYRROLATE: New indication approved
FDAcompleted
Jul 2018GLYCOPYRROLATE: New indication approved
FDAcompleted
Mar 2014

GLYCOPYRROLATE: New indication approved

FDAcompleted
Jul 2010

Cuvposa: FDA approved

To reduce chronic drooling in patients aged 3 - 16 with neurologic conditions associated with problem drooling (e.g. cerebral palsy)

FDAcompleted
May 2005GLYCOPYRROLATE: New indication approved
FDAcompleted
Nov 2004GLYCOPYRROLATE: New indication approved
FDAcompleted
Jun 2003GLYCOPYRROLATE: New indication approved
FDAcompleted

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for Neurometabolic disorder due to serine deficiency.
Check the disease page for updates →

Clinical Trial Landscape

No active clinical trials currently recruiting for Neurometabolic disorder due to serine deficiency.
Search all trials →
Search clinical trials for Neurometabolic disorder due to serine deficiency

Recent News & Research

No recent news articles indexed yet for Neurometabolic disorder due to serine deficiency.
Search PubMed for Neurometabolic disorder due to serine deficiency

Browse all Neurometabolic disorder due to serine deficiency news →

Specialist Network

Top 1 by expertise

View all Neurometabolic disorder due to serine deficiency specialists →

Quick Actions